# Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations

> **NCT04960384** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 52 (actual)

## Conditions studied

- Tympanic Membrane Perforation

## Interventions

- **DRUG:** FGF-2
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04960384
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-27
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-10-27
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04960384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04960384, "Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04960384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*